Sponsor:
Suven Life Sciences Limited
Code:
NCT05397639
Conditions
Agitation
Alzheimer's Type Dementia
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Masupirdine 50 mg
Masupirdine 100 mg
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-10. This information was provided to ClinicalTrials.gov by Suven Life Sciences Limited on 2025-05-20.